Vernon, Suzanne D, Unger, Elizabeth R, Dimulescu, Irina M et al. · Disease markers · 2002 · DOI
Researchers examined blood cells from people with ME/CFS and healthy volunteers to see if they could find differences in how genes are turned on or off. They found that blood cells from ME/CFS patients showed different gene activity patterns compared to healthy people, and some of these differences involved immune system genes. This suggests that ME/CFS involves problems with how the immune system is functioning.
This study provides molecular evidence that ME/CFS involves measurable differences in immune gene expression, offering potential for developing objective blood tests to help diagnose the condition. Identifying specific genes involved could lead to better understanding of disease mechanisms and potential treatment targets.
This study does not prove that these gene expression changes cause ME/CFS—they may be consequences of the illness rather than causes. The small sample size and single-site design mean results require independent replication before they can be reliably used as diagnostic biomarkers. The study also does not determine whether gene expression differences are specific to ME/CFS or shared with other conditions.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.